The Medicare Part B Discarded Drug Units dataset provides spending information on claims for Medicare Part B drugs that were identified as having discarded amounts of a drug. As of January 1, 2017, the Centers for Medicare & Medicaid Services (CMS) requires all physicians, hospitals, and other providers submitting claims for Medicare Part B drugs to report any discarded amount of a single use vial or other single use package drug on its claim for payment. With the passage of the Infrastructure Investment and Jobs Act in November 2021, manufacturers must pay a refund to Medicare for discarded amounts above a specified threshold effective for drugs furnished beginning with January 1, 2023.

2014-2019. This dataset is a de-identified summary table of vision and eye health data indicators from Medicare claims, stratified by all available combinations of age group, race/ethnicity, gender, and state. Medicare claims for VEHSS includes beneficiaries who were fully enrolled in Medicare Part B Fee-for-Service (FFS) for the duration of the year. Medicare claims provide a convenience sample that includes approximately 30 million individuals annually, which represents nearly 89% of the US population aged 65 and older and 3.3% of the US population younger than 65, including persons disabled due to blindness. Medicare data for VEHSS include Service Utilization and Medical Diagnoses indicators. Data were suppressed for de-identification to ensure protection of patient privacy. Data will be updated as it becomes available. Detailed information on VEHSS Medicare analyses can be found on the VEHSS Medicare webpage (cdc.gov/visionhealth/vehss/data/claims/medicare.html). Information on available Medicare claims data can be found on the ResDac website (www.resdac.org). The VEHSS Medicare dataset was last updated May 2023.